Table 4.
Characteristics | Dead Participants | Survived Participants | ORs (95% Confidence Interval) for Mortality | |||||||
---|---|---|---|---|---|---|---|---|---|---|
(Exposure/Total, %) | (Exposure/Total, %) | Crude | p-Value | Model 1 † | p-Value | Model 2 ‡ | p-Value | Model 3 § | p-Value | |
Hypothyroidism | 6/237 (2.5%) | 278/7833 (3.5%) | 0.71 (0.31–1.60) | 0.406 | 0.48 (0.19–1.20) | 0.115 | 0.51 (0.20–1.28) | 0.152 | 0.51 (0.20–1.27) | 0.147 |
Hyperthyroidism | 4/237 (1.7%) | 130/7833 (1.7%) | 1.02 (0.37–2.78) | 0.973 | 1.69 (0.55–5.17) | 0.359 | 2.32 (0.74–7.30) | 0.152 | N/A | |
Graves’ disease | 1/237 (0.4%) | 19/7833 (0.2%) | 1.74 (0.23–13.07) | 0.589 | 5.77 (0.70–47.74) | 0.104 | N/A | 11.43 (1.29–101.22) | 0.029 * | |
Thyroiditis | 0/237 (0.0%) | 108/7833 (1.4%) | N/A | N/A | N/A | N/A | ||||
Autoimmune thyroiditis | 0/237 (0.0%) | 52/7833 (0.7%) | N/A | N/A | N/A | N/A |
CCI: Charlson comorbidity index; N/A: not applicable. * Unconditional logistic regression model, significance at p < 0.05. † Model 1 was adjusted for age, sex, income, CCI scores, and hypertension. ‡ Model 2 was adjusted for model 1 plus hypothyroidism, hyperthyroidism, and thyroiditis. § Model 3 was adjusted for model 1 plus hypothyroidism, Graves’ disease, and autoimmune thyroiditis.